Solventum Corporation
90.03USD
-0.0800 (-0.09%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,209 | 2,007 | 1,998 | 2,096 | 2,161 | 2,070 | 2,075 | 2,082 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | 1,286 | 1,097 | 1,027 | 1,135 | 1,175 | 1,114 | 1,119 | 1,165 |
| Operating Income | 181 | 81 | 124 | 1,690 | 214 | 152 | 136 | 275 |
| Net Income | 92 | 13 | 63 | 1,266 | 90 | 137 | 31 | 122 |
| EPS (Diluted) | $0.53 | $0.07 | $0.35 | $7.22 | $0.51 | $0.78 | $0.18 | $0.70 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)